Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5846720 | Toxicology and Applied Pharmacology | 2012 | 11 Pages |
Abstract
⺠We study Eriocalyxin B (EriB)'s cytotoxic effects on pancreatic cancer cell lines. ⺠EriB inhibits cell proliferation via mediation of apoptosis and cell cycle arrest. ⺠The effects are involved in caspase-dependent apoptosis and p53 pathway. ⺠In vivo study also shows EriB inhibits the growth of human pancreatic tumor. ⺠EriB can be a good candidate for chemotherapy in pancreatic cancer.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Lin Li, Grace G.L. Yue, Clara B.S. Lau, Handong Sun, Kwok Pui Fung, Ping Chung Leung, Quanbin Han, Po Sing Leung,